Commercial, Energy Efficiency, GHG Emissions - January 26, 2024
Catalent Sets 2030 Goals, Gets Validated by SBTi
Catalent, Inc., a company enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply, announced its targets to lower GHG emissions (Scope 1 and 2) by 42% by 2030.
The company also committed to engaging with its suppliers so that 70% of their emissions will have reduction goals aligned with science-based targets by the end of fiscal 2028. These targets were validated by the Science Based Targets initiative (SBTi).
“Our mission to deliver products that help people live better lives goes hand in hand with our commitment to environmental responsibility and actions to limit climate change,” said Alessandro Maselli, President and Chief Executive Officer of Catalent, Inc., in a statement. “As a leading contract manufacturing and development organization, it’s important that we are guided by science-based targets and that we hold our partners accountable to the same standards so that we can make progress for a more sustainable future.”
Catalent’s SBTi-approved targets include lowering absolute Scope 1 and Scope 2 GHG emissions by 42% by fiscal 2030 against a fiscal 2022 baseline year, as well as reducing absolute Scope 3 GHG emissions from fuel- and energy-related activities and employee commuting by 25% within the same timeframe.
Catalent achieved its initial carbon reduction goal ahead of time through site-based energy reduction projects and transitioning the majority of its sites to renewable electricity.
In July 2021, the company signed a letter of commitment with the SBTi.
Catalent also conducted its first Scope 3 inventory in fiscal 2023 that revealed that over 80% of its emissions are generated by its value chain. Catalent has strengthened and expanded its SBTi targets for Scope 3 to multiply impact through its suppliers. The company implemented a supplier engagement program to increase sustainability improvements and support and monitor progress of its SBTi target along the value chain.
Stay Up-To-Date